Geneos Wealth Management’s ESAB ESAB Stock Holding History

Geneos Wealth Management’s Portfolio ESAB Stock Details ESAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-39	Closed	-$4.7K	–	2708
2025 Q2	$4.7K	Hold	39	–	–	﹤0.01%	2600
2025 Q1	$4.54K	Buy	+39	New	+$4.75K	﹤0.01%	2544

Other funds holding ESAB

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geneos Wealth Management's ESAB Position: Q3 2025 in Review

Geneos Wealth Management sold out of ESAB (ESAB) in Q3 2025, closing a stake of 39 shares — an estimated $4.7K sold.

Geneos Wealth Management first reported a position in ESAB in Q1 2025 and held it in 2 quarters. The position peaked at $4.7K in Q2 2025. 362 funds tracked by Wall St. Rank hold ESAB as of Q3 2025.

Geneos Wealth Management reported no remaining ESAB position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 39 ESAB shares in Q3 2025, an estimated $4.7K.
Geneos Wealth Management first reported a position in ESAB in Q1 2025 and held it in 2 quarters.
Geneos Wealth Management's ESAB position peaked at $4.7K in Q2 2025.
362 funds tracked by Wall St. Rank held ESAB as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.